Burhan Turgut

The outcome of COVID‐19 in patients with hematological malignancy

Tuğçe Nur Yiğenoğlu, Naim Ata, Fevzi Altuntaş et al. · Journal of Medical Virology · 2020 · 129 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Intensive Care Unit +15

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa et al. · The Lancet · 2023 · 77 citations · Full text

Thrombopoiesis, Autoimmune Disease, Blood Platelet +11

Increased circulating platelet–neutrophil, platelet–monocyte complexes, and platelet activation in patients with ulcerative colitis: A comparative study

Gülsüm Emel Pamuk, Özden Vural, Burhan Turgut et al. · American Journal of Hematology · 2006 · 73 citations

Healthy Subjects, Immunology, Gastroenterology +19

Increased platelet activation markers in rheumatoid arthritis: Are they related with subclinical atherosclerosis?

Gülsüm Emel Pamuk, Özden Vural, Burhan Turgut et al. · Platelets · 2008 · 65 citations

Vascular Disease, Immunology, Pathology +26

The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein

Sibel Güldiken, Muzaffer Demir, Ender Arıkan et al. · Thrombosis Research · 2006 · 65 citations

Inflammation, Soluble Cd40 Ligand, Vascular Disease +11